引用次数
引用: 97,872
H-指数: 126
I10-指数 : 359
出版物: 787
Cell-free DNA (c.f.D.N.A) recapitulates genomic profile of renal cell carcinoma (R.C.C) and corresponds to disease progression and therapy response
L Au , HX Xu , AR Rowan , KL Litchfield
European Urology Supplements 17 ( 10)
2018
Cell-free DNA--based multi-cancer early detection test in an asymptomatic screening population (NHS-Galleri): design of a pragmatic, prospective randomised controlled trial
Richard D Neal , Peter Johnson , Christina A Clarke , Stephanie A Hamilton
Cancers 14 ( 19) 4818
6
2022
New Targets and Innovative Strategies in Cancer Treatment: one year of progress. 13-14 February 2004, Nice, France.
Stephen Johnston , Charles Swanton
IDrugs : the investigational drugs journal 7 ( 4) 306 -311
1
2004
Chromosomal instability determines taxane sensitivity - supplementary materials
Maik Kschischo , Barbara Nicke , Thomas Ried , Julian Downward
2009
Circulating tumour cells as liquid biopsies in clinical studies: the example of TRACERx.
Fiona H Blackhall , Philip A J Crosbie , Ged Brady , Caroline Dive
2018
Abstract B49: “Triple wild-type” co-mutational profile in early-stage KRAS-mutant lung cancer
Fiona Blackhall , Jane Rogan , Colin R. Lindsay , Lynsey Priest
Molecular Cancer Research 18
2020
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Sine R. Hadrup , Nicholas McGranahan , Tariq Enver , Andrew J.S. Furness
Cell 184 ( 3)
325
2021
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories.
Robert E Hynds , Robert E Hynds , Kristopher K Frese , Caroline Dive
Open Biology 11 ( 1) 200247 -200247
2021
A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms.
Charles Swanton , Bernadett Szikriszt , Ádám Póti , Nnennaya Kanu
Mutagenesis 36 ( 1) 75 -86
2021
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay
Michael D Buck , Enzo Z Poirier , Ana Cardoso , Bruno Frederico
Wellcome Open Research 6 9
2021
Characterisation of tumour immune microenvironment remodelling following oncogene inhibition in preclinical studies using an optimised imaging mass cytometry workflow
Febe van Maldegem , Miriam Molina-Arcas , Julian Downward , Julian Downward
bioRxiv
1
2021
A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer
Laura Andrejka , Le Cong , Dmitri A Petrov , Maryam Yousefi
Cancer Discovery
21
2021
Understanding the impact of immune-mediated selection on lung cancer evolution.
Nicholas McGranahan , Rachel Rosenthal , Rachel Rosenthal , Charles Swanton
British Journal of Cancer 124 ( 10) 1615 -1617
2021
Spatial patterns of tumour growth impact clonal diversification: computational modelling and evidence in the TRACERx Renal study
Xiao Fu , Yue Zhao , Jose Lopez , Andrew Rowan
2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
Sara Busacca , Joanna Dzialo , Tamihiro Kamata , Essa Y Baitei
Nature Communications 12 ( 1) 1751 -1751
3
2021
Method for treating cancer
Nicholas Mcgranahan , Rachel Rosenthal , Sergio Quezada , Charles Swanton
5
2016
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
Stefan C Dentro , Ignaty Leshchiner , Kerstin Haase , Maxime Tarabichi
Cell 184 ( 8) 2239
4
2021
Cytokine release syndrome in a patient with colorectal cancer following vaccination with BNT162b2 (tozinameran)
Charlotte Fribbens , Naureen Starling , Ian Chau , Andrew Furness
2021
Tracking Cancer Evolution through the Disease Course.
Nicholas McGranahan , Kevin Litchfield , Chris Bailey , Samra Turajlic
Cancer Discovery 11 ( 4) 916 -932
44
2021
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity.
Giuseppe Filomeni , Apolinar Maya-Mendoza , Jirina Bartkova , Letizia Lanzetti
Nature 592 ( 7856) 799 -803
58
2021